nodes	percent_of_prediction	percent_of_DWPC	metapath
Canagliflozin—CYP3A4—Temozolomide—malignant glioma	0.111	1	CbGbCtD
Canagliflozin—SLC5A1—Disease—FGF2—malignant glioma	0.000528	0.000594	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—FGF2—malignant glioma	0.000528	0.000594	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000526	0.000592	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PIK3CG—malignant glioma	0.000525	0.000591	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PIK3CG—malignant glioma	0.000525	0.000591	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000525	0.00059	CbGpPWpGaD
Canagliflozin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	0.000522	0.000587	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—PTK2—malignant glioma	0.000519	0.000584	CbGpPWpGaD
Canagliflozin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	0.000518	0.000583	CbGpPWpGaD
Canagliflozin—ALB—Platelet degranulation—VEGFA—malignant glioma	0.000507	0.000571	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PPARG—malignant glioma	0.000507	0.000571	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PPARG—malignant glioma	0.000507	0.000571	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—TNF—malignant glioma	0.000507	0.00057	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—MDM2—malignant glioma	0.000494	0.000556	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—MDM2—malignant glioma	0.000494	0.000556	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—HIST1H3B—malignant glioma	0.000492	0.000554	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—RAF1—malignant glioma	0.000492	0.000554	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—RAF1—malignant glioma	0.000492	0.000554	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000492	0.000553	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—MYB—malignant glioma	0.000488	0.000549	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—ERBB2—malignant glioma	0.000487	0.000548	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—ERBB2—malignant glioma	0.000487	0.000548	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000487	0.000548	CbGpPWpGaD
Canagliflozin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—malignant glioma	0.000483	0.000544	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—IDH2—malignant glioma	0.000481	0.000542	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—PIK3CB—malignant glioma	0.000481	0.000541	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—PIK3CB—malignant glioma	0.000481	0.000541	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000478	0.000537	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—PTGS2—malignant glioma	0.000476	0.000536	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—PTGS2—malignant glioma	0.000476	0.000536	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000471	0.00053	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PIK3CD—malignant glioma	0.000462	0.00052	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PIK3CD—malignant glioma	0.000462	0.00052	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000454	0.000511	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CYP2B6—malignant glioma	0.000453	0.000509	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—VEGFA—malignant glioma	0.000449	0.000505	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—TP53—malignant glioma	0.000447	0.000503	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—CAV1—malignant glioma	0.000445	0.000501	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	0.000436	0.00049	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000427	0.00048	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—PTEN—malignant glioma	0.000415	0.000467	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—PTEN—malignant glioma	0.000415	0.000467	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—IDH1—malignant glioma	0.000414	0.000466	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PIK3CG—malignant glioma	0.000406	0.000456	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—TNF—malignant glioma	0.000403	0.000453	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PIK3CB—malignant glioma	0.000403	0.000453	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PIK3CB—malignant glioma	0.000403	0.000453	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—SPHK1—malignant glioma	0.000401	0.000451	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PTGS2—malignant glioma	0.000399	0.000449	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PTGS2—malignant glioma	0.000399	0.000449	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—F2—malignant glioma	0.000393	0.000442	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—FN1—malignant glioma	0.000393	0.000442	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CYP2C18—malignant glioma	0.000392	0.000442	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PPARG—malignant glioma	0.000391	0.000441	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—COX8A—malignant glioma	0.000391	0.00044	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—TNF—malignant glioma	0.000385	0.000433	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000382	0.00043	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—H3F3A—malignant glioma	0.00038	0.000428	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	0.000376	0.000423	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—EGF—malignant glioma	0.000372	0.000418	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—STAT3—malignant glioma	0.000371	0.000418	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—STAT3—malignant glioma	0.000371	0.000418	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.00037	0.000417	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.00037	0.000416	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000368	0.000414	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000366	0.000412	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000364	0.000409	CbGpPWpGaD
Canagliflozin—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000359	0.000404	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PIK3CD—malignant glioma	0.000357	0.000401	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.00035	0.000394	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PTEN—malignant glioma	0.000348	0.000391	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PTEN—malignant glioma	0.000348	0.000391	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—MYC—malignant glioma	0.000345	0.000388	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—MYC—malignant glioma	0.000345	0.000388	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—AKT2—malignant glioma	0.000344	0.000387	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—COX8A—malignant glioma	0.000343	0.000386	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—EGFR—malignant glioma	0.000338	0.00038	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—EGFR—malignant glioma	0.000338	0.00038	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000337	0.000379	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ASMT—malignant glioma	0.000333	0.000374	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000332	0.000374	CbGpPWpGaD
Canagliflozin—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000331	0.000372	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	0.000331	0.000372	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000325	0.000366	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000325	0.000366	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—KRAS—malignant glioma	0.000319	0.000359	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—KRAS—malignant glioma	0.000319	0.000359	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GSTT1—malignant glioma	0.000317	0.000357	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—KNG1—malignant glioma	0.000313	0.000353	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—BCAN—malignant glioma	0.000313	0.000352	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000312	0.000351	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PIK3CB—malignant glioma	0.000311	0.00035	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PTGS2—malignant glioma	0.000308	0.000347	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—IFNA2—malignant glioma	0.000307	0.000346	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000305	0.000344	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PTGS1—malignant glioma	0.000297	0.000335	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000296	0.000333	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000296	0.000333	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—RAF1—malignant glioma	0.000295	0.000332	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—PIK3CA—malignant glioma	0.000293	0.00033	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—PIK3CA—malignant glioma	0.000293	0.00033	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000292	0.000328	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ASMT—malignant glioma	0.000291	0.000328	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000291	0.000328	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—SOD1—malignant glioma	0.000291	0.000328	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000291	0.000327	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000291	0.000327	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	0.000288	0.000324	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000288	0.000324	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000281	0.000316	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—BCHE—malignant glioma	0.000277	0.000311	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—BCAN—malignant glioma	0.000274	0.000308	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—SLC5A5—malignant glioma	0.000273	0.000307	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PTEN—malignant glioma	0.000269	0.000302	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000268	0.000301	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PTK2—malignant glioma	0.000267	0.000301	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	0.000265	0.000298	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000261	0.000294	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000258	0.000291	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000256	0.000288	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000255	0.000287	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—IDH2—malignant glioma	0.000252	0.000284	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000245	0.000276	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PIK3CA—malignant glioma	0.000245	0.000276	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PIK3CA—malignant glioma	0.000245	0.000276	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000245	0.000276	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—AKT1—malignant glioma	0.000239	0.000269	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—AKT1—malignant glioma	0.000239	0.000269	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000238	0.000267	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CYP2B6—malignant glioma	0.000237	0.000267	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	0.000225	0.000253	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PDGFB—malignant glioma	0.000225	0.000253	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000223	0.000251	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000221	0.000249	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—IDH2—malignant glioma	0.000221	0.000249	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GSTP1—malignant glioma	0.00022	0.000248	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—IDH1—malignant glioma	0.000217	0.000244	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CAT—malignant glioma	0.000214	0.000241	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—CAV1—malignant glioma	0.000213	0.00024	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—COX8A—malignant glioma	0.000211	0.000238	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—SPHK1—malignant glioma	0.00021	0.000236	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CYP2B6—malignant glioma	0.000208	0.000234	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CYP2C18—malignant glioma	0.000205	0.000231	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000204	0.000229	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—F2—malignant glioma	0.000203	0.000228	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—FN1—malignant glioma	0.000203	0.000228	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—NCOR1—malignant glioma	0.000202	0.000228	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—AKT1—malignant glioma	0.0002	0.000226	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—AKT1—malignant glioma	0.0002	0.000226	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000199	0.000224	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PIK3CG—malignant glioma	0.000194	0.000218	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000194	0.000218	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—EGF—malignant glioma	0.000192	0.000216	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PTPN11—malignant glioma	0.00019	0.000214	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—IDH1—malignant glioma	0.00019	0.000214	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.00019	0.000214	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PIK3CA—malignant glioma	0.000189	0.000213	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000188	0.000212	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SPHK1—malignant glioma	0.000184	0.000207	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CYP2C18—malignant glioma	0.00018	0.000203	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ASMT—malignant glioma	0.00018	0.000202	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—AKT2—malignant glioma	0.000177	0.0002	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000176	0.000199	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	0.000176	0.000198	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000173	0.000195	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PIK3CD—malignant glioma	0.00017	0.000192	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.00017	0.000192	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—BCAN—malignant glioma	0.000169	0.00019	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000167	0.000188	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GSTT1—malignant glioma	0.000166	0.000187	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CAV1—malignant glioma	0.000165	0.000185	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000157	0.000177	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PTGS1—malignant glioma	0.000156	0.000175	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000155	0.000175	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—AKT1—malignant glioma	0.000155	0.000174	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—RAF1—malignant glioma	0.000152	0.000171	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PIK3CG—malignant glioma	0.00015	0.000169	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PIK3CB—malignant glioma	0.000149	0.000167	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GSTT1—malignant glioma	0.000146	0.000164	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PPARG—malignant glioma	0.000145	0.000163	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—BCHE—malignant glioma	0.000145	0.000163	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	0.000144	0.000162	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—SLC5A5—malignant glioma	0.000143	0.000161	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000141	0.000159	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PTGS1—malignant glioma	0.000136	0.000154	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—IL2—malignant glioma	0.000136	0.000154	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—IDH2—malignant glioma	0.000136	0.000153	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000135	0.000152	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000134	0.000151	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PIK3CD—malignant glioma	0.000132	0.000149	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000132	0.000148	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CYP2B6—malignant glioma	0.000128	0.000144	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—BCHE—malignant glioma	0.000127	0.000143	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SLC5A5—malignant glioma	0.000125	0.000141	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—IDH1—malignant glioma	0.000117	0.000132	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000117	0.000132	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—VEGFA—malignant glioma	0.000116	0.00013	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000115	0.00013	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GSTP1—malignant glioma	0.000115	0.00013	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PIK3CB—malignant glioma	0.000115	0.000129	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PTGS2—malignant glioma	0.000114	0.000128	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SPHK1—malignant glioma	0.000113	0.000127	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CAT—malignant glioma	0.000112	0.000126	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CYP2C18—malignant glioma	0.000111	0.000125	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—NCOR1—malignant glioma	0.000106	0.000119	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GSTP1—malignant glioma	0.000101	0.000114	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PTEN—malignant glioma	9.94e-05	0.000112	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—KRAS—malignant glioma	9.86e-05	0.000111	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CAT—malignant glioma	9.82e-05	0.000111	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—NCOR1—malignant glioma	9.27e-05	0.000104	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PIK3CA—malignant glioma	9.06e-05	0.000102	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GSTT1—malignant glioma	8.97e-05	0.000101	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—TP53—malignant glioma	8.76e-05	9.86e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CAV1—malignant glioma	8.63e-05	9.71e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PTGS1—malignant glioma	8.41e-05	9.46e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.24e-05	9.28e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PIK3CG—malignant glioma	7.86e-05	8.85e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—BCHE—malignant glioma	7.82e-05	8.79e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SLC5A5—malignant glioma	7.72e-05	8.69e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PPARG—malignant glioma	7.59e-05	8.54e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CAV1—malignant glioma	7.56e-05	8.51e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—AKT1—malignant glioma	7.4e-05	8.32e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PIK3CA—malignant glioma	7.01e-05	7.89e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PIK3CD—malignant glioma	6.91e-05	7.78e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PIK3CG—malignant glioma	6.89e-05	7.75e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PPARG—malignant glioma	6.65e-05	7.48e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GSTP1—malignant glioma	6.22e-05	7e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PIK3CD—malignant glioma	6.05e-05	6.81e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CAT—malignant glioma	6.05e-05	6.81e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PIK3CB—malignant glioma	6.02e-05	6.78e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PTGS2—malignant glioma	5.97e-05	6.72e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—AKT1—malignant glioma	5.73e-05	6.45e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—NCOR1—malignant glioma	5.71e-05	6.43e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PIK3CB—malignant glioma	5.28e-05	5.94e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PTGS2—malignant glioma	5.23e-05	5.88e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PTEN—malignant glioma	5.2e-05	5.86e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CAV1—malignant glioma	4.66e-05	5.24e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PTEN—malignant glioma	4.56e-05	5.13e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PIK3CG—malignant glioma	4.24e-05	4.77e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PPARG—malignant glioma	4.1e-05	4.61e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.73e-05	4.2e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PIK3CA—malignant glioma	3.67e-05	4.13e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.25e-05	3.66e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PTGS2—malignant glioma	3.22e-05	3.63e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PIK3CA—malignant glioma	3.22e-05	3.62e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—AKT1—malignant glioma	3e-05	3.38e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PTEN—malignant glioma	2.81e-05	3.16e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—AKT1—malignant glioma	2.63e-05	2.96e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.98e-05	2.23e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—AKT1—malignant glioma	1.62e-05	1.82e-05	CbGpPWpGaD
